Novonesis provides outlook for 2024 with expected 5-7% organic sales growth and ~35% adj. EBITDA margin. Pro forma financials disclosed. Ester Baiget, CEO of Novonesis, said: “Today we provide key pro ...

The unaudited pro forma condensed combined financial information includes a balance sheet as of September 30, 2025 and statements of operations for the nine months ended September ...

The MarketWatch News Department was not involved in the creation of this content. SINGAPORE, Aug. 29, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd (NASDAQ: GCL) ("GCL" or the "Company"), a leading ...

AtaiBeckley Inc. (NASDAQ:ATAI) filed a report Friday with the U.S. Securities and Exchange Commission providing additional information related to its acquisition of Beckley Psytech Limited, a company ...

The latest announcement is out from RedHill Biopharma ( (RDHL)). On October 17, 2025, RedHill Biopharma completed a strategic transaction with Cumberland Pharmaceuticals involving Talicia®, its ...

Auddia Inc. (NASDAQ:AUUD) filed an 8-K with the Securities and Exchange Commission on Friday, providing audited financial statements of Thramann Holdings, LLC and its subsidiaries for the years ended ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Freight Technologies, Inc. (Nasdaq: FRGT, "Fr8Tech" or the "Company"), a logistics management innovation company offering a diverse portfolio of technology-driven ...

The unaudited pro forma condensed combined statements of income and comprehensive income combine the audited consolidated statement of income and comprehensive income of GCL for the year ended March ...